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Abstract
Background: The Erythrocyte Binding Antigen (EBA) 175 has been considered as one of the most important
Plasmodium falciparum (P. falciparum) merozoite ligands that mediate invasion of the erythrocytes through their
sialated receptor: Glycophorin A (GPA). The effect of the EBA 175 dimorphic alleles (F and C) on the severity of the
disease is not yet fully understood. Therefore this study was designed to assess the distribution of the divergent
dimorphic alleles of P. falciparum EBA-175 (F and C) in three different geographical areas in Sudan and the possible
association of this dimorphism with the severity of the disease.
Methods: A sum of 339 field isolates of P. falciparum obtained from patients in three different geographical areas
in Sudan were screened for the dimorphic alleles (F, C) of the EBA-175 using nested PCR.
Results: The percentage of F, C, and mixed F/C alleles were; 41%, 51%, and 8% respectively. F and C alleles showed
significantly different distributions in the various geographic areas (p = 0.00). There was no significant association
between malaria clinical manifestation and P. falciparum EBA-175 F and C alleles frequencies.
Conclusions: This study showed a significant differential distribution of F and C alleles in different geographical
malaria endemic areas. No significant association was observed between F and C alleles and different malaria
phenotypes.
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Background
In the pathogenesis of the malaria parasite, P. falciparum
merozoites invade the erythrocytes through multiple
ligand-receptor interactions [1-4] providing an oppor-
tunity for using alternative invasion pathways if one has
been blocked [5]. This illustrates the vital importance
of using multiple ligand-receptor interactions for the
P. falciparum merozoites.
Some P. falciparum strains mainly use ligands that bind
to sialated receptors of the erythrocyte, other strains use
ligands that bind to receptors independently of sialic acid.
However, switching from sialic acid dependent to inde-
pendent invasion is reversible and depends on the parasite
ligand used [3,5]. Disruption of this binding through
modification of the erythrocyte surface or by gene disrup-
tion has shown that the merozoites can use other invasion
pathways [5,6]. This means that switching from sialic
acid-dependent to sialic acid-independent invasion is pos-
sible but the genetic bases of this process are unknown
[7,8]. One of the most essential P. falciparum merozoites
ligands is the (EBA-175), which utilizes the sialated eryth-
rocytes receptor, GPA, the major glycophorin found on
human erythrocytes, in order to invade the red blood cell
[1,9,10]. This antigen is located in the microneme organ-
elles at the apical end of merozoites and belongs to a
family of parasite adhesion molecules, the Duffy- Binding-
like erythrocyte-binding proteins (DBL-EBP) [11]. EBA-
175 consists of 7 regions, in region II at the N terminus
there are two cystine rich segments (F1, F2) responsible
for binding to the GPA [9,11]. It is well established that
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the gene that encodes the EBA-175 has a highly divergent
dimorphic segments of sequences in region III, the
first one detected in the FCR3 strains of P. falciparum
“referred to as the F loop” and the second one in CAMP
strains “referred to as the C loop” [12,13]. F and C seg-
ments which are inserted at different positions in the cod-
ing sequence of exon 1 encode 141 and 114 amino-acid
respectively. These two divergent segments are conserved
in all P. falciparum examined up to date and since mero-
zoites are haploid; each parasite has a C or F segment, but
not both or neither [14]. In spite of the role of this di-
morphism in host-parasite interaction is unclear, different
studies have shown that the initial interaction of merozo-
ite invasion involves binding of F or C segment to the
GPA backbone after binding of region II “of EBA-175” to
sialic acid residues of GPA [14,15]. Furthermore, it has
been reported that the majority of P. falciparum merozo-
ites use the erythrocytic GPA receptor in the invasion
process [16]. Studies to determine distribution of F and C
segments dimorphism among parasite populations from
five different African countries including Sudan, showed
that Sudan has the most divergent population with C
allele frequency of 0.73 [17]. Another study among
Ghanaian children showed that the C segment is not asso-
ciated with severe malaria but confers a higher risk of fatal
disease [18].
Therefore, this study was designed to study firstly, the
distribution of the divergent dimorphic alleles of P.
falciparum EBA-175 (F and C) in three different malaria
endemic areas in Central and Eastern Sudan and
secondly, the possible association of this dimorphism
with the outcome of the disease.
Methods
Study area and subjects
This study is a cross-sectional carried out in November
2007 and December 2009. It was conducted in three
regions; in the Eastern region (Um-Salala village) and
the Central region of the Sudan (Wad Madani and
Sennar). Um-Salala is a small village inhabited by a sin-
gle tribe of ~1,200 people by 1997, and characterized by
stable malaria transmission. Wad Madani and Sennar
are two big cities located in central Sudan with a popula-
tion size of 452,628 and 1.2 million respectively. Both
are inhabited by multiple tribes and characterized by
unstable malaria transmission [19].
The study was approved by the Ethical committee of the
institute of endemic diseases, University of Khartoum.
Informed consents were obtained from adults or parents
of children before they were enrolled in the study. A ques-
tionnaire form includes information about the family and
clinical picture for each participant was completed. Per-
ipheral blood samples were collected from a total of 339
microscopically confirmed P. falciparum infected malaria
patients from the three different malaria endemic areas;
Um-Salala 57 samples, Sennar 166 samples and Wad
Madani 116 samples. Depending on the World Health
Organization (WHO) criteria of severe malaria, a report
revised in the year 2000 [20] symptomatic severe malaria,
symptomatic uncomplicated malaria, and asymptomatic
malaria of all ages were involved. Two ml of whole blood
samples were collected in heparinized tubes from all con-
firmed malaria cases with a positive blood film (BF). An-
other blood film and Immunochromatography test (ICT)
(BinaxNOW® Malaria test) were performed according to
the manufacturer instructions, not only to confirm the in-
fection, but also to differentiate between different malaria
plasmodium species, as P. falciparum is the only species
under study. The BinaxNOW® Malaria ICT test targets
the histidine-rich protein II (HRPII) antigen specific to
P. falciparum and a pan-malarial antigen (PMA), common
to all four malaria species capable of infecting humans - P.
falciparum, P. vivax, P. ovale, and P. malariae.
DNA extraction
Chelex extraction method was used for DNA extraction
from whole blood spotted and dried on filter papers.
Each filter paper punch was incubated overnight at 4°C
in 1 mL of 0.5% saponin in phosphate-buffered saline
(PBS). The punches were washed for 30 minutes in
1 mL PBS at 4°C, transferred into new tubes containing
25 μL of 20% Chelex-100 and 75 μL of distilled water,
and vortexed for 30 seconds. The tubes were heated at
99°C for 15 minutes to elute DNA, vortexed, and
centrifuged at 10,000 × g for 2 minutes. The superna-
tants, which contained the DNA, were carefully removed
and transferred into new tubes [21].
Nested PCR and product analysis
In order to confirm the infection with P. falciparum,
nested PCR that was used as described previously [22]
using 10 mM of each of the following universal oligo-
nucleotide primers; inner PCR forward Primer (rPLU1):
5′tcaaagattaagccatgcaagtga3′, inner PCR reverse primer
(rPLU5): 5′cctgttgttgccttaaacttc3′, outer PCR forward
Primer (rFAL1): 5′ttaaactggtttgggaaaaccaaatatatt3′, and
outer PCR reverse primer (rFAL2): 5′acacaatgaactcaat
catgactacccgtc3′. The samples that showed specific P.
falciparum bands of 205 bp in 2% agarose were selected
for a further nested PCR to genotype the EBA-175 di-
morphism using specific primers described previously
[23] as follow (GenBank database, accession number
L7755): EBA1 forward (nucleotides 2336–2356) 5′caa
gaagcagttcctgaggaa3′ EBA2 reverse (nucleotides 3060–
3083) 5′tctcaacattcatattaacaattc3′ for the first amplifica-
tion (PCR); EBA3 forward (nucleotides 2351–2364) 5′
gaggaaaacactgaaatagcacac3′ and EBA4 reverse (nucleo-
tides 3042–3065) 5′caattcctccagactgttgaacat3′ for the
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second (nested) amplification. The following protocol
was used for both the first and nested PCR; Hot start at
95°C for 5 minutes. Thirty cycles of denaturation at 95°C
for 1 minute, primer annealing at 58°C for 1 minute,
extension at 70°C for 2 minutes, and final extension at
72°C for 10 minutes. The volume used for each reaction
is 25 μl. A master mix containing all reagents, except
DNA, is prepared and aliquoted into the reaction tubes.
The master mix for the first and nested PCR contains
the same following reagents for one single test tube ex-
cept for the set of the primers: 1.5 mM MgCl2, 2.5 μl of
10X PCR buffer, 10 mM dNTPs, 10 mM from each pri-
mer, 2 μl DNA, and 5 Unit Taq polymerase, 1 μl bovine
serum albumin and 14.8 μl of dH2O. The second PCR end
products were separated in agarose gel electrophoresis at
1.5% concentration and visualized using a gel documenta-
tion system (BioDoc-It Imaging System, Cambridge, UK)
for the presence of 714 bp or 795 bp bands representing
the C and F segments respectively. The presence of both
bands indicates a co-infection with at least two different
P. falciparum clones.
Statistical analysis
Statistical analysis was carried out using the SPSS
software version 9. F and C Alleles frequencies among
populations were calculated, firstly collectively in all
populations, secondly in each of the three different study
areas separately. In order to determine the possible asso-
ciation between allele distributions and severity of the
disease, comparison between genotypes and phenotypes
were carried out using the Chi-squared test. The same
test was used to detect the significance of the distribu-
tion of different alleles among the overall population.




The total number of participants recruited in this study
was 339 of which 57 from Um-Salala, 166 from Sennar
and 116 from Wad Madani. Patients were with different
malaria phenotype were included: 276 mild, 37 Asymp-
tomatic and 35 severe. The group of severe malaria
includes: 20 individuals less than five years of age with
severe anemia, hyperpyrexia, convulsion and hyperpara-
sitemia; the other 15 individuals were more than 10 years
of age with hyperpyrexia, convulsion, anemia and
hypoglycemia. The age of patients from all three study
areas ranged from 1 year to 85 years, where 80% of the
patients were less than 20 years old. The age average
was 11.86 ± 11.02. Sex ratio was 1:1. The haemoglobin
levels ranged from 4.4 g/dl– 18.0 g/dl with an average of
10.1 ± 1.8, and glucose levels ranged from 23–205 mg/dl,
with an average of 105.6 ± 33.9 mg/dl.
Distribution of F and C genotypes in the study areas
A total of 339 P. falciparum positive blood samples from
three different geographical areas have been examined
for the dimorphic alleles F and C (Figure 1), they showed
the following frequencies: 41.0% F, 51.0% C and 8.0% of
the samples carried both F and C alleles.
In Sennar area, out of 166 samples, the prevalence of
F, C, and mixed F/C genotypes were 55 (33.13%), 95
(57.23%), and 16 (9.64%) respectively. In Wad Madani,
out of 116 samples, 43 (37.07%) were genotyped as F, 66
(56.90%) as C, and 7 (6.03%) as mixed F/C segments.
The total number of samples from Um-Salala village
were 57 samples out of which, 41(71.9%) showed the F
allele, 12 (21.1%) were genotyped as C, and 4 (7.0%) car-
ries a mixed alleles, F/C. The difference of the F and C
alleles distribution among the different study areas col-
lectively was significant (p-value = 0.00). No significant
differences in the distribution of alleles in central Sudan-
Sennar and Wad Madani (p-value = 0.4983).
The distribution of C and F alleles was assessed in four
different age groups; less than 5 years, 5–10 years, 11–
20 years and more than 20 years. No significant differ-
ence of C and F alleles frequencies within the different
age groups (P-value = 0.28).
Association of F and C genotypes with the phenotypes
Malaria phenotypes of all patients were categorized
according to thecWHO criteria into three main groups:
asymptomatic, mild, and severe malaria [20]. All malaria
cases from Um-Salala were mild; the other two pheno-
types were found in Sennar and Wad Madani (Figure 2).
The Chi-squared test was used for all three groups col-
lectively. There were no significant differences in the
distribution of F and C alleles among the asymptomatic,
mild and severe cases (p = 0.297). The genotypes distri-
bution among Sennar mild cases were 33.13% F allele,
57.23% C allele and 8.64% carried both alleles, while there
were no F among the five Sennar severe cases, but 3 of C
and 2 of F/C alleles. Out of 116 malaria cases from Wad
Figure 1 Distribution of F and C alleles in the three
study areas.
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Madani, 37 were asymptomatic, 49 mild, and 30 severe
cases. No association between genotypes and phenotypes
was detected.
Eleven asymptomatic malaria patients from Wad Madani
showed positive result for sickle cell test. The prevalence of
F, C and mixed F/C segments among sicklers were 36.4%,
63.6%, and 0% respectively.
In Um-Salala village the 57 malaira patients were
presented by mild malaria. The genotypes distribution
was (72%) for the F allele, (21%) for the C allele and
(7%) carried both alleles F/C.
Association of F and C alleles with parasitemia
Using unpaired (independent) t- test, the parasitemia of
132 samples from central Sudan were related to F and C
genotypes, the average parasitemia among C and F al-
leles carriers was 38317.9/μl, and 35485.7/μl respectively
with no significant difference (P-value = 0.86).
Discussion
Assessment of C and F distribution in 339 P. falciparum
positive blood samples from three different geographical
areas showed that both fragment types, C and F, had
nearly the same distribution within the population of
Wad Madani and Sennar, being 56.9% and 37.1%,
respectively in Wad Madani and 57.23% and 33.13%,
respectively in Sennar area. The percentage of the
co-infection with both alleles C/F was 6% and 9.64% for
Wad Madani and Sennar respectively. The parasites
population in Wad Madani and Sennar, can be consid-
ered as a single gene pool because of their geographical
proximity which may lead to an admixture. The two cit-
ies are close to each other so there is frequent popula-
tion movement between these two big cities.
The distribution of the F allele in the third region
(Um-Salala, Eastern Sudan), was markedly higher than
that of the C allele. This could be due to location of
Um-Salala village in remote area which is inaccessible
during rainy season and could be described as semi
isolated area. In addition to that this village is inhabited
by one ethnic group of the Massalit tribe and in
comparison with Sennar and Wad Madani their big
cities subjected to population movement and this will
lead to populations admixture and parasite diversity.
Moreover there is only one single transmission peak
symphonized with Anopheles arabiensis after the short
rainy season in Um-Salala village [24]. This result dis-
agrees with a previous study by Binks [17] that took
place in Eastern Sudan (Daraweesh and Asar villages)
and four other countries in Africa, where they reported
that the distribution of the C allele in Eastern Sudan was
markedly higher than that of F allele. However the high
frequency of F allele in Um-Salala is similar to that
obtained in the Lao PDR, Iran in Asia and Gabon and
Burkina Faso in Africa [25-28]. A study took place in four
malaria endemic areas in Burkina Faso among children
under five years, showed that in both low and high malaria
transmission seasons, F- allele was more prevalent than
the C-allele. This implies that the distribution of F and C
alleles is not affected by seasonal variation [28].
While the malaria pattern in Um-Salala is character-
ized by asymptomatic and mild forms, in Wad Madani
the asymptomatic cases are relatively few and almost
non for Sennar, where most of the cases were mild but
some with severe symptoms.
In order to detect the effect of the dimorphic allele’s
distribution on the out come of the disease, we com-
pared the distribution to the phenotypes of the disease,
which was categorized into three groups: Asymptomatic,
mild, and severe malaria. There were no significant
differences in the distribution of F and C among asymp-
tomatic, mild, and severe clinical forms of malaria among
whole populations from the three study areas collectively,
p = 0.297. Our finding is similar to Heidari and his
colleagues [27] as they concluded that there was no sig-
nificant correlation between clinical outcomes and the
EBA-175 fragment types in their study area in Iran. When
eleven sickler cases infected with P. falciparum were
genotyped for F and C fragments, we observed that the C
allele was found to be more frequent than F allele, 7: 4 C
to F respectively. This finding contradicts Cramer’s study
[18] and suggests an uncoupling of the C allele and viru-
lence, as the sickle cell trait shows strong resistance to
severe and complicated malaria [29,30]. The Clinically
protected human hosts, including sicklers, are known to
get immunity faster than others due to modulated im-
mune response [31,32]. Sicklers were found to have
antiparasitic as well as anti inflammatory cytokine
responses [33]. The higher frequency of the C allele
among sicklers may suggest a survival advantage for
these parasites in these clinically protected individuals
since they never seek treatment. This survival advantage
may render sicklers into safe reservoirs for the C allele
parasites. If this is the case, sicklers would help in the
wide distribution of the C allele parasites in the societies
Figure 2 Association of the F and C alleles with malaria
clinical manifestations.
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among whom the sickle gene exists. The overall results
of the effect of sickle haemoglobin (HbS) trait on the
differential selection of F and C alleles needs verification
by increasing the sample size.
Furthermore, to find out the relationship between this
dimorphism and severity of the disease, F and C distri-
bution was correlated to the parasitemia level of subset
of infected individuals. There was no significant differ-
ence in average of parasitemia in F and C allele’s carriers.
This result is concurrence with Heidari et al. [26] who
didn’t find significant correlation between parasitemia,
gender, age of subjects and clinical outcome with the
two fragments of EBA-175 gene.
Conclusions
This study showed a significant differential distribution
of F and C fragments in different geographical areas
endemic with malaria. It could explain the different pat-
terns of malaria in Um-Salala village and cities in central
Sudan. More studies on larger populations are needed to
understand the distributional pattern of EBA-175 alleles
according to the clinical outcomes of the disease.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HSM conceived the study, substantial contributions to conception and
design, field work, interpretation of data and drafting the manuscript. NHA
participated in coordination of the study, recruitment of cases and helped in
revising the manuscript. AAMA, involved in the collection of the samples, all
field laboratory work, DNA extraction, genotyping and acquisition of data.
DAH and WHO are involved in the recruitment of cases and sample
collection. AAA contributes in all field laboratory work, sample collection and
genotyping. BYN contributes in field station setting and sample collection.
AZJ contributes in analysis of the data. MEI involved in coordination of the
study and revising the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We thank the people who agreed to participate in this study from Um Salala,
Sennar and Wad Medani. We are grateful for the assistance of the field and
laboratory teams in Sudan, who contributed to this study. The field work of
this study was supported by the Ministry of Health, Sudan and BioMalPar.
Author details
1Institute of Endemic Diseases, University of Khartoum, P.O. Box 102,
Khartoum, Sudan. 2Central Laboratory, Ministry of Science and Technology,
P.O. Box 8076, Khartoum, Sudan. 3University of Gezira, Wad Medani, Sudan.
4Prince Sultan Military College of Health Sciences, Dhahran, KSA, Sudan.
5College of Pharmacy, The National Rebat University, P.O. Box 55, Khartoum,
Sudan.
Received: 3 May 2013 Accepted: 7 October 2013
Published: 9 October 2013
References
1. Camus D, Hadley TJ: A Plasmodium falciparum antigen that binds to host
erythrocytes and merozoites. Science 1985, 230:553–556.
2. Mitchell GH, Hadley TJ, McGinniss MH, Klotz FW, Miller LH: Invasion of
erythrocytes by Plasmodium falciparum malaria parasites: evidence for
receptor heterogeneity and two receptors. Blood 1986, 67:1519–1521.
3. Hadley TJ, Klotz FW, Pasvol G, Haynes JD, McGinniss MH, et al: Falciparum
malaria parasites invade erythrocytes that lack glycophorin A and B
(MkMk). Strain differences indicate receptor heterogeneity and two
pathways for invasion. J Clin Invest 1987, 80:1190–1193.
4. Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW: A
Plasmodium falciparum homologue of Plasmodium vivax reticulocyte
binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion
pathway. J Exp Med 2001, 194:1571–1581.
5. Duraisingh MT, Maier AG, Triglia T, Cowman AF: Erythrocyte-binding
antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic
acid-dependent and -independent pathways. Proc Natl Acad Sci USA 2003,
100:4796–4801.
6. Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, et al: Targeted
disruption of an erythrocyte binding antigen in Plasmodium falciparum
is associated with a switch toward a sialic acid-independent pathway of
invasion. Proc Natl Acad Sci USA 2000, 97:7509–7514.
7. Gaur D, Mayer DC, Miller LH: Parasite ligand-host receptor interactions
during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol
2004, 34:1413–1429.
8. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, et al: Molecular
mechanism for switching of P. falciparum invasion pathways into human
erythrocytes. Science 2005, 309:1384–1387.
9. Orlandi PA, Sim BK, Chulay JD, Haynes JD: Characterization of the 175-
kilodalton erythrocyte binding antigen of Plasmodium falciparum.
Mol Biochem Parasitol 1990, 40:285–294.
10. Marchesi VT, Tillack TW, Jackson RL, Segrest JP, Scott RE: Chemical
characterization and surface orientation of the major glycoprotein of
the human erythrocyte membrane. Proc Natl Acad Sci USA 1972,
69:1445–1449.
11. Adams JH, Sim BK, Dolan SA, Fang X, Kaslow DC, et al: A family of
erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA
1992, 89:7085–7089.
12. Kain KC, Lanar DE: Determination of genetic variation within
Plasmodium falciparum by using enzymatically amplified DNA from
filter paper disks impregnated with whole blood. J Clin Microbiol 1991,
29:1171–1174.
13. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH: Receptor and ligand
domains for invasion of erythrocytes by Plasmodium falciparum.
Science 1994, 264:1941–1944.
14. Ware LA, Kain KC, Lee Sim BK, Haynes JD, Baird JK, et al: Two alleles of the
175-kilodalton Plasmodium falciparum erythrocyte binding antigen.
Mol Biochem Parasitol 1993, 60:105–109.
15. Kain KC, Orlandi PA, Haynes JD, Sim KL, Lanar DE: Evidence for two-stage
binding by the 175-kD erythrocyte binding antigen of Plasmodium
falciparum. J Exp Med 1993, 178:1497–1505.
16. Baum J, Pinder M, Conway DJ: Erythrocyte invasion phenotypes of
Plasmodium falciparum in the Gambia. Infect Immun 2003, 71:1856–1863.
17. Binks RH, Baum J, Oduola AM, Arnot DE, Babiker HA, et al: Population
genetic analysis of the Plasmodium falciparum erythrocyte binding
antigen-175 (eba-175) gene. Mol Biochem Parasitol 2001, 114:63–70.
18. Cramer JP, Mockenhaupt FP, Mohl I, Dittrich S, Dietz E, et al: Allelic
dimorphism of the erythrocyte binding antigen-175 (eba-175) gene of
Plasmodium falciparum and severe malaria: significant association of the C-
segment with fatal outcome in Ghanaian children. Malar J 2004, 3:11.
19. Himeidan YE, Elbashir MI, Rayah E, El A, Adam I: Epidemiology of malaria in
New Halfa, an irrigated area in eastern Sudan. East Mediterr Health J 2005,
11:499–504.
20. World Health Organization (WHO): Severe falciparum malaria. Trans R Soc
Trop Med Hyg 2000, 94:1.
21. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE: Pyrimethamine
and proguanil resistance-conferring mutations in Plasmodium
falciparum dihydrofolatereductase: polymerase chain reaction methods
for surveillance in Africa. Am J Trop Med Hyg 1995, 52:565–568.
22. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, et al: High sensitivity
of detection of human malaria parasites by the use of nested
polymerase chain reaction. Mol Biochem Parasitol 1993, 61:315–320.
23. Toure FS, Mavoungou E, Ndong JM, Tshipamba P, Deloron P: Erythrocyte
binding antigen (EBA-175) of Plasmodium falciparum: improved
genotype determination by nested polymerase chain reaction. Trop Med
Int Health 2001, 6:767–769.
24. Himeidan YE, Elzaki MM, Kweka EJ, Ibrahim M, Elhassan IM: Pattern of
malaria transmission along the Rahad River basin. Eastern Sudan.
Parasit Vectors 2011, 4:109.
Adam et al. BMC Infectious Diseases 2013, 13:469 Page 5 of 6
http://www.biomedcentral.com/1471-2334/13/469
25. Dittrich S, Schwobel B, Jordan S, Vanisaveth V, Rattanaxay P, et al:
Distribution of the two forms of Plasmodium falciparum erythrocyte
binding antigen-175 (eba-175) gene in Lao PDR. Malar J 2003, 2:23.
26. Toure FS, Bisseye C, Mavoungou E: Imbalanced distribution of Plasmodium
falciparum EBA-175 genotypes related to clinical status in children from
Bakoumba, Gabon. Clin Med Res 2006, 4:7–11.
27. Heidari A, Keshavarz H, Dittrich S, Jelinek T: Allelic Dimorphism of the P.
falciparum Erythrocyte Binding Antigen 175 (EBA-175) Gene in the
Southeast of Iran. Iranian J Parasitol 2009, 4:17–22.
28. Soulama I, Bougouma EC, Diarra A, Nebie I, Sirima SB: Low-high season
variation in Plasmodium falciparum erythrocyte binding antigen 175
(eba-175) allelic forms in malaria endemic area of Burkina Faso. Trop Med
Int Health 2010, 15:51–59.
29. Allison AC: Polymorphism and Natural Selection in Human Populations.
Cold Spring Harb Symp Quant Biol 1964, 29:137–149.
30. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, TerKuile FO, et al: Protective
effects of the sickle cell gene against malaria morbidity and mortality.
Lancet 2002, 359:1311–1312.
31. Bayoumi RA: The sickle-cell trait modifies the intensity and specificity of
the immune response against P. faleiparum malaria and leads to
acquired protective immunity. Med Hypotheses 1987, 22:287–298.
32. Verra F, Simpore J, Warimwe GM, Tetteh KK, Howard T, Osier FH, Bancone G,
Avellino P, Blot I, Fegan G, Bull PC, Williams TN, Conway DJ, Marsh K,
Modiano D: Haemoglobin C and S role in acquired immunity against
Plasmodium falciparum malaria. PLoS One 2007, 3:2(10).
33. Hassan DA, Marques C, Santos-Gomes GM, DoRosario VE, Mohamed HS,
et al: Differential expression of cytokine genes among sickle-cell-trait
(HbAS) and normal (HbAA) children infected with Plasmodium
falciparum. Ann Trop Med Parasitol 2009, 103:283–295.
doi:10.1186/1471-2334-13-469
Cite this article as: Adam et al.: Distribution of erythrocyte binding
antigen 175 (EBA-175) gene dimorphic alleles in Plasmodium falciparum
field isolates from Sudan. BMC Infectious Diseases 2013 13:469.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Adam et al. BMC Infectious Diseases 2013, 13:469 Page 6 of 6
http://www.biomedcentral.com/1471-2334/13/469
